Starting Dose of Haloperidol for Acute Agitation
The recommended starting dose of haloperidol for acute agitation in adults is 5 mg intramuscularly, which can be combined with lorazepam 2-4 mg IM for superior efficacy. 1
Standard Dosing Protocol
Initial Dose
- Haloperidol 5 mg IM is the most extensively studied and effective starting dose for acute agitation and psychosis in adults 2, 1
- This dose produces significant reduction in agitation within 28-30 minutes on average 1
- The 5 mg dose has been consistently validated across multiple randomized trials as superior to lower doses (1-2 mg) 3
Combination Therapy (Preferred Approach)
- Adding lorazepam 2-4 mg IM to haloperidol 5 mg produces significantly greater agitation reduction than either drug alone 2, 1
- The combination achieves faster sedation (15-30 minutes vs 28 minutes for haloperidol alone) and requires fewer repeat doses 2, 1
- Alternative combination: haloperidol 10 mg with promethazine 25-50 mg produces more rapid tranquilization at 15,30,60, and 120 minutes compared to lorazepam 4 mg alone 2
Redosing Strategy
- If inadequate response, repeat dosing can occur at 30-minute to 1-hour intervals 1
- Maximum of 3-4 injections may be given in the initial control phase 3
- Efficacy shows dose-response relationship up to 10-15 mg; above this, there is diminished improvement 4
Route-Specific Dosing
Oral Administration (FDA-Approved)
For patients who can accept oral medication:
- Moderate symptoms: 0.5-2 mg twice or three times daily 5
- Severe symptoms: 3-5 mg twice or three times daily 5
- Oral haloperidol 15 mg daily has demonstrated efficacy for rapid tranquilization within 2 hours in severely agitated patients 6
Special Populations
- Geriatric or debilitated patients: 0.5-2 mg twice or three times daily (oral) 5
- First-episode psychosis: Start with 2 mg daily, as many patients respond to doses well below common usage levels 7
Critical Safety Considerations
Immediate Precautions
- Have diphenhydramine or benztropine immediately available for acute dystonic reactions (20% risk of extrapyramidal symptoms) 1, 4
- Monitor for QTc prolongation; avoid haloperidol if baseline QTc is prolonged 1
- Watch for neuroleptic malignant syndrome (hyperpyrexia, rigidity, altered mental status, autonomic instability) 1
Common Pitfalls to Avoid
- Do not escalate to large doses (>15-20 mg) during early treatment, as this results in excessive dosing and side effects without hastening recovery 1
- Do not use haloperidol monotherapy when combination with benzodiazepines is more effective for acute agitation 1
- Recognize that immediate effects are primarily sedation, not true antipsychotic response, which takes 4-6 weeks to properly assess 1
- Do not use haloperidol in anticholinergic or sympathomimetic toxicity, as it can exacerbate agitation due to anticholinergic side effects 2
Comparative Context
- Haloperidol 5 mg IM produces similar overall sedation to lorazepam 2 mg, though lorazepam acts more rapidly at 1-3 hours 2
- Midazolam 5 mg achieves faster sedation (18.3 minutes) compared to haloperidol 5 mg (28.3 minutes) 2, 1
- Atypical antipsychotics like ziprasidone 20 mg IM may be better tolerated with lower movement disorder rates, though haloperidol remains highly effective 2, 8